Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiji Yano

Showing results (11-20 of 286) with videos related to

Pageof 29
Sort By:
Cancer Science|March 23, 2012
Ligand-triggered resistance to molecular targeted drugs in lung cancer: roles of hepatocyte growth factor and epidermal growth factor receptor ligandsSeiji Yano, Shinji Takeuchi, Takayuki Nakagawa, et al.
Journal of Surgical Oncology|March 24, 2017
Liver parenchyma transection-first approach in hemihepatectomy with en bloc caudate lobectomy for hilar cholangiocarcinoma: A safe technique to secure favorable surgical outcomesYasunari Kawabata, Hikota Hayashi, Seiji Yano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 15, 2007
[Differences in the therapeutic strategies for lung cancer between Europe/United States and Japan]Masaki Hanibuchi, Seiji Yano, Hideki Tomimoto, et al.
International Cancer Conference Journal|January 6, 2025
Successful osimertinib treatment for Meckel's cave metastasis: a case reportKazuhiko Iwasaki, Satoshi Watanabe, Yusuke Ikku, et al.
Respiratory Investigation|September 14, 2023
Home high-flow nasal therapy in a patient with pleuroparenchymal fibroelastosis: A case reportKazuhiko Iwasaki, Satoshi Watanabe, Akihito Okazaki, et al.
International Journal of Molecular Sciences|December 1, 2020
Effective RNA Knockdown Using CRISPR-Cas13a and Molecular Targeting of the <i>EML4-ALK</i> Transcript in H3122 Lung Cancer CellsSaifullah, Matomo Sakari, Takeshi Suzuki, et al.
Journal of Biochemistry|May 13, 2016
Proteolytic inactivation of anti-angiogenic vasohibin-1 by cancer cellsMegumu Saito, Yasuhiro Suzuki, Seiji Yano, et al.
Oncology Research|April 12, 2003
Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patientsTakanori Kanematsu, Seiji Yano, Hisanori Uehara, et al.
The Journal of Medical Investigation : JMI|March 24, 2007
Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusionsHideki Tomimoto, Seiji Yano, Hiroaki Muguruma, et al.
Cancer Science|March 12, 2014
Not just gRASping at flaws: finding vulnerabilities to develop novel therapies for treating KRAS mutant cancersHiromichi Ebi, Anthony C Faber, Jeffrey A Engelman, et al.
Pageof 29

Showing results (11-20 of 286) with videos related to

Sort By:
Pageof 29
Cancer Science|March 23, 2012
Ligand-triggered resistance to molecular targeted drugs in lung cancer: roles of hepatocyte growth factor and epidermal growth factor receptor ligandsSeiji Yano, Shinji Takeuchi, Takayuki Nakagawa, et al.
Journal of Surgical Oncology|March 24, 2017
Liver parenchyma transection-first approach in hemihepatectomy with en bloc caudate lobectomy for hilar cholangiocarcinoma: A safe technique to secure favorable surgical outcomesYasunari Kawabata, Hikota Hayashi, Seiji Yano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 15, 2007
[Differences in the therapeutic strategies for lung cancer between Europe/United States and Japan]Masaki Hanibuchi, Seiji Yano, Hideki Tomimoto, et al.
International Cancer Conference Journal|January 6, 2025
Successful osimertinib treatment for Meckel's cave metastasis: a case reportKazuhiko Iwasaki, Satoshi Watanabe, Yusuke Ikku, et al.
Respiratory Investigation|September 14, 2023
Home high-flow nasal therapy in a patient with pleuroparenchymal fibroelastosis: A case reportKazuhiko Iwasaki, Satoshi Watanabe, Akihito Okazaki, et al.
International Journal of Molecular Sciences|December 1, 2020
Effective RNA Knockdown Using CRISPR-Cas13a and Molecular Targeting of the <i>EML4-ALK</i> Transcript in H3122 Lung Cancer CellsSaifullah, Matomo Sakari, Takeshi Suzuki, et al.
Journal of Biochemistry|May 13, 2016
Proteolytic inactivation of anti-angiogenic vasohibin-1 by cancer cellsMegumu Saito, Yasuhiro Suzuki, Seiji Yano, et al.
Oncology Research|April 12, 2003
Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patientsTakanori Kanematsu, Seiji Yano, Hisanori Uehara, et al.
The Journal of Medical Investigation : JMI|March 24, 2007
Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusionsHideki Tomimoto, Seiji Yano, Hiroaki Muguruma, et al.
Cancer Science|March 12, 2014
Not just gRASping at flaws: finding vulnerabilities to develop novel therapies for treating KRAS mutant cancersHiromichi Ebi, Anthony C Faber, Jeffrey A Engelman, et al.
Pageof 29